Flubendazole With Herxheimer Reactions Followed by a Cure in a Patient With Symptoms Suggestive of Chronic Lyme

August 19, 2024

https://www.fortunejournals.com/articles/effect-of-flubendazole-with-jarishherxheimer-reactions-followed-by-cure-in-a-patient-with-a-polymorphic-persistent-syndrome-sugges.

Effect of Flubendazole, with Jarish-Herxheimer Reactions Followed by Cure, in A Patient with A Polymorphic Persistent Syndrome Suggestive of Chronic Lyme Disease: A Sign of Parasitic Disease?

Article Information

Alexis Lacout1, Christian Perronne2

1Centre de diagnostic ELSAN, Centre médico-chirurgical 83 avenue Charles de Gaulle 15000 Aurillac, France

2Infectious Diseases, Paris

*Corresponding author: Alexis Lacout. Centre de diagnostic ELSAN, Centre médico-chirurgical 83 avenue Charles de Gaulle 15000 Aurillac, France

Received: 02 February 2023; Accepted: 09 February 2023; Published: 13 March 2024

Citation: Alexis Lacout, Christian Perronne. Effect of Flubendazole, with Jarish-Herxheimer Reactions Followed by Cure, in A Patient with A Polymorphic Persistent Syndrome Suggestive of Chronic Lyme Disease: A Sign of Parasitic Disease. Archives of Microbiology and Immunology. 8 (2024): 96-100.

View / Download PdfShare at Facebook

Abstract

This paper discusses the case of a 40-year-old male patient presenting with a “polymorphic persistent syndrome after a possible tick bite” (SPPT), a syndrome officially recognized by the French High Authority for Health (HAS). Anti-infection protocols were implemented, gradually improving the patient’s clinical condition until complete remission was achieved. Each time flubendazole was taken, it was accompanied by severe symptoms – not suggestive of adverse reactions but of a Jarisch-Herxheimer reaction. Each administration of flubendazole was followed by a period of remission of symptoms.  ________________

**Comment**

Please note study author Dr. Christian Perronne, a long outspoken critic of how Lyme has been handled as well as COVID.  He’s yet another doctor who has been persecuted for this departure from ‘consensus’ based medicine where doctors are expected to check their brains at the door and simply follow illogical and unscientific government dictates.

Flubendazole is a antiparasitic (anthelmintic) agent and a fluorine analogue of mebendazole which is better absorbed when taken with or after a meal.  Used as a dewormer in humans and animals for 40 years, recent studies suggest its potential use as an anticancer agent.  The same can be said of Fenbendazole (Fedben).

I highly recommend viewing Dr. Lee Merrit’s 50 Min video: The Parasite Paradigm.  Parasite egg sacks and cancer look identical under a microscope and German scientists have been saying for decades that cancer is caused by parasites.  Her protocols are found here.

Flubendazole is also available in a slow-release parenteral preparation given subcutaneously or intramuscularly, which allows sustained release over 5 days. The usual dosage is 750 mg/wk for onchocerciasis. It is used to treat hookworm, T. trichiura, and A. lumbricoides. Side effects are vague and mostly abdominal, such as nausea, abdominal pain and rumbling, soft/loose stools, and dyspepsia.  Breathlessness and fatigue have also been reported.

For more on Perronne’s work:

Category:

Activism, Cancer, Lyme, Parasites, research, Treatment

Comments Off on Flubendazole With Herxheimer Reactions Followed by a Cure in a Patient With Symptoms Suggestive of Chronic Lyme